Ramoplanin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ramoplanin" in English language version.

refsWebsite

Global rank English rank

10nih.gov

4^th place

9doi.org

2^nd place

2semanticscholar.org

11^th place

8^th place

1figshare.com

5,893^rd place

3,320^th place

doi.org

Farver DK, Hedge DD, Lee SC (May 2005). "Ramoplanin: a lipoglycodepsipeptide antibiotic". The Annals of Pharmacotherapy. 39 (5): 863–868. doi:10.1345/aph.1E397. PMID 15784805. S2CID 6026698.
Lee VJ (2007-01-01). "7.22 - Anti-Gram Positive Agents of Natural Product Origins". In Taylor JB, Triggle DJ (eds.). Comprehensive Medicinal Chemistry. Vol. II. Oxford: Elsevier. pp. 653–671. doi:10.1016/b0-08-045044-x/00222-4. ISBN 978-0-08-045044-5.
Fulco P, Wenzel RP (December 2006). "Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent". Expert Review of Anti-Infective Therapy. 4 (6): 939–945. doi:10.1586/14787210.4.6.939. PMID 17181409. S2CID 12881565.
Balagopal A, Sears CL (October 2007). "Clostridium difficile: new therapeutic options". Current Opinion in Pharmacology. 7 (5): 455–458. doi:10.1016/j.coph.2007.05.007. PMID 17644040.
Gerding DN, Muto CA, Owens RC (January 2008). "Treatment of Clostridium difficile infection". Clinical Infectious Diseases. 46 (Suppl 1): S32 – S42. doi:10.1086/521860. PMID 18177219.
Fang X, Tiyanont K, Zhang Y, Wanner J, Boger D, Walker S (January 2006). "The mechanism of action of ramoplanin and enduracidin". Molecular BioSystems. 2 (1): 69–76. doi:10.1039/b515328j. PMID 16880924.
Shin D, Rew Y, Boger DL (August 2004). "Total synthesis and structure of the ramoplanin A1 and A3 aglycons: two minor components of the ramoplanin complex". Proceedings of the National Academy of Sciences of the United States of America. 101 (33): 11977–11979. doi:10.1073/pnas.0401419101. PMC 514419. PMID 15175429.
Hoertz AJ, Hamburger JB, Gooden DM, Bednar MM, McCafferty DG (January 2012). "Studies on the biosynthesis of the lipodepsipeptide antibiotic Ramoplanin A2". Bioorganic & Medicinal Chemistry. 20 (2): 859–865. doi:10.1016/j.bmc.2011.11.062. PMID 22222159.
Jiang W, Wanner J, Lee RJ, Bounaud PY, Boger DL (February 2003). "Total synthesis of the ramoplanin A2 and ramoplanose aglycon". Journal of the American Chemical Society. 125 (7): 1877–1887. doi:10.1021/ja0212314. PMID 12580615.

figshare.com

Jiang W, Wanner J, Lee RJ, Bounaud PY, Boger DL (February 2003). "Total synthesis of the ramoplanin A2 and ramoplanose aglycon". Journal of the American Chemical Society. 125 (7): 1877–1887. doi:10.1021/ja0212314. PMID 12580615.

nih.gov

pubmed.ncbi.nlm.nih.gov

Farver DK, Hedge DD, Lee SC (May 2005). "Ramoplanin: a lipoglycodepsipeptide antibiotic". The Annals of Pharmacotherapy. 39 (5): 863–868. doi:10.1345/aph.1E397. PMID 15784805. S2CID 6026698.
Fulco P, Wenzel RP (December 2006). "Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent". Expert Review of Anti-Infective Therapy. 4 (6): 939–945. doi:10.1586/14787210.4.6.939. PMID 17181409. S2CID 12881565.
Scheinfeld N (January 2007). "A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus". Journal of Drugs in Dermatology. 6 (1): 97–103. PMID 17373167.
Balagopal A, Sears CL (October 2007). "Clostridium difficile: new therapeutic options". Current Opinion in Pharmacology. 7 (5): 455–458. doi:10.1016/j.coph.2007.05.007. PMID 17644040.
Gerding DN, Muto CA, Owens RC (January 2008). "Treatment of Clostridium difficile infection". Clinical Infectious Diseases. 46 (Suppl 1): S32 – S42. doi:10.1086/521860. PMID 18177219.
Fang X, Tiyanont K, Zhang Y, Wanner J, Boger D, Walker S (January 2006). "The mechanism of action of ramoplanin and enduracidin". Molecular BioSystems. 2 (1): 69–76. doi:10.1039/b515328j. PMID 16880924.
Shin D, Rew Y, Boger DL (August 2004). "Total synthesis and structure of the ramoplanin A1 and A3 aglycons: two minor components of the ramoplanin complex". Proceedings of the National Academy of Sciences of the United States of America. 101 (33): 11977–11979. doi:10.1073/pnas.0401419101. PMC 514419. PMID 15175429.
Hoertz AJ, Hamburger JB, Gooden DM, Bednar MM, McCafferty DG (January 2012). "Studies on the biosynthesis of the lipodepsipeptide antibiotic Ramoplanin A2". Bioorganic & Medicinal Chemistry. 20 (2): 859–865. doi:10.1016/j.bmc.2011.11.062. PMID 22222159.
Jiang W, Wanner J, Lee RJ, Bounaud PY, Boger DL (February 2003). "Total synthesis of the ramoplanin A2 and ramoplanose aglycon". Journal of the American Chemical Society. 125 (7): 1877–1887. doi:10.1021/ja0212314. PMID 12580615.

ncbi.nlm.nih.gov

Shin D, Rew Y, Boger DL (August 2004). "Total synthesis and structure of the ramoplanin A1 and A3 aglycons: two minor components of the ramoplanin complex". Proceedings of the National Academy of Sciences of the United States of America. 101 (33): 11977–11979. doi:10.1073/pnas.0401419101. PMC 514419. PMID 15175429.

semanticscholar.org

api.semanticscholar.org

Farver DK, Hedge DD, Lee SC (May 2005). "Ramoplanin: a lipoglycodepsipeptide antibiotic". The Annals of Pharmacotherapy. 39 (5): 863–868. doi:10.1345/aph.1E397. PMID 15784805. S2CID 6026698.
Fulco P, Wenzel RP (December 2006). "Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent". Expert Review of Anti-Infective Therapy. 4 (6): 939–945. doi:10.1586/14787210.4.6.939. PMID 17181409. S2CID 12881565.